The Analgesia Effect of Electroacupuncture Battlefield Acupuncture Versus Sham Electroakupuncture Post Surgery
- Conditions
- Percutaneous Nephrolithotomy
- Registration Number
- NCT06783556
- Lead Sponsor
- Indonesia University
- Brief Summary
The goal of this clinical trial is to learn the effect of ear electroacupuncture BFA therapy in reducing pain, analgesic dose, and improving patient quality of live post percutaneous nephrolithotomy surgery. The main questions it aims to answer are:
* Does BFA ear electroacupuncture reduce postoperative pain of percutaneous nephrolithotomy surgery better than sham electroacupuncture group?
* Does BFA ear electroacupuncture reduce postoperative analgesic dose of percutaneous nephrolithotomy surgery better than sham electroacupuncture group?
* Does BFA ear electroacupuncture improve postoperative quality of life of percutaneous nephrolithotomy surgery better than sham electroacupuncture group?
Researchers will compare ear electroacupuncture BFA to sham electroacupuncture to see the different analgesia effect between these groups.
Participants will:
* Get ear electroacupuncture BFA or sham electroacupuncture therapy, 2 hours before surgery for 30 minutes
* Take drug paracetamol 1000 mg intravenous after surgery according to the needs of the patient's pain complaints after surgery in both groups
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 30
- Men or women aged 18-65 years
- Patients who have been diagnosed with kidney stones measuring > 2 cm and will undergo PCNL surgery
- VAS score <7, assessed 2 hours before PCNL surgery
- Receive standard analgesic therapy
- Willing to participate in this study until completion and sign an informed consent.
- Kidney anatomical abnormalities
- Ear deformities (microtia)
- Patients with cognitive impairment, uncooperative (receiving antidepressants or strong opioid or narcotic analgesics)
- Tumors, wounds or skin infections in the needling area.
- Heart rhythm disorder, unstable hemodynamics that require intensive care including extremely high body temperature and using a pacemaker.
- Allergy to acupuncture needles or certain metals
- Patients who have had a DJ stent or nephrostomy before PCNL
- History of metal implants in the body except amalgam
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method Visual Analogue Scale Before therapy, minute 0, hour 8, hour 24, hour 48 Visual Analogue Scale is the tool that measures pain intensity. It use a scale with a minimum range of 0 and a maximum of 10, where 0 indicates no pain and 10 indicates the worst pain. Higher scores indicate worse pain.
- Secondary Outcome Measures
Name Time Method Analgesic dose reduction hour 8, hour 24, hour 48 Paracetamol 1000 mg IV is given to patient with a maximum of 3 times administration per 24 hours. The dose of paracetamol can be reduced when the patien's pain score of Visual Analogue Score is less than 3. Measurements were made by measuring the cumulative dose of analgesics after acupuncture therapy. Then compared between the two groups, which group had a greater decrease in analgesic dose.
Short Form 36 (SF-36) Questionnaire Before therapy, day 7 The SF-36 questionnaire consists of eight scales yielding two summary measures: physical and mental health. The physical health measure includes four scales of physical functioning (10 items), role-physical (4 items), bodily pain (2 items), and general health (5 items). The mental health measure is composed of vitality (4 items), social functioning (2 items), role-emotional (3 items), and mental health (5 items). To score the SF-36, scales are standardized with a scoring algorithm to obtain a score ranging from 0 to 100. Higher scores indicate better health status.
Adverse effects Day 7 Record the adverse effects that occur after acupuncture therapy. It will be monitored for 7 days after therapy and recorded on the 7th day by assessor.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Universitas Indonesia
🇮🇩Jakarta Pusat, Dki Jakarta, Indonesia